CORC

在结果中检索

CORC

浏览/检索结果: 共422条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文
CANCER LETTERS, 2024, 卷号: 582, 页码: 15
作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia
收藏  |  浏览/下载：2/0  |  提交时间：2024/04/07
Catalytic oxidation properties of 3D printed ceramics with Bouligand structures 期刊论文
Chemical Engineering Journal, 2023, 卷号: 474, 期号: 无, 页码: 145504
作者:  Xu X(徐昕);  He B(何波);  Wang YX(汪祎贤);  Xi YT(席云泰);  Liu DS(刘德胜)
收藏  |  浏览/下载：111/0  |  提交时间：2023/10/31
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei
收藏  |  浏览/下载：7/0  |  提交时间：2023/11/10
Catalytic oxidation properties of 3D printed ceramics with Bouligand structures 期刊论文
Chemical Engineering Journal, 2023, 期号: 474, 页码: 145504
作者:  Xin Xu;  Bo He;  Yixian Wang;  Yuntai Xi;  Desheng Liu
收藏  |  浏览/下载：30/0  |  提交时间：2024/01/02
Design and Application of a Deep-Sea Engineering Geology In Situ Test System 期刊论文
MINERALS, 2023, 卷号: 13, 期号: 2, 页码: 1
作者:  Zhong, Kaiming;  Chen, Ming;  Xie, Chao;  Zheng, Jinrong;  Chen, Wei
收藏  |  浏览/下载：8/0  |  提交时间：2023/04/14
Targeting KRAS mutant cancers: from druggable therapy to drug resistance 期刊论文
MOLECULAR CANCER, 2022, 卷号: 21
作者:  Zhu, Chunxiao;  Guan, Xiaoqing;  Zhang, Xinuo;  Luan, Xin;  Song, Zhengbo
收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi
收藏  |  浏览/下载：17/0  |  提交时间：2022/05/05
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载：90/0  |  提交时间：2022/03/28
The Cycas genome and the early evolution of seed plants 期刊论文
NATURE PLANTS, 2022, 卷号: 8, 期号: 4, 页码: 389+
作者:  Liu, Yang;  Wang, Sibo;  Li, Linzhou;  Yang, Ting;  Dong, Shanshan
收藏  |  浏览/下载：0/0  |  提交时间：2024/03/07

©版权所有 ©2017 CSpace - Powered by CSpace